Please login to the form below

Not currently logged in
Email:
Password:

London Genetics senior appointments

London Genetics has made three appointments to its board and management team

London Genetics, which expedites pharmacogenetic partnerships between the biopharmaceutical industry and London-based centres of genetics research, has made three appointments to its board and management team.

Dr Barrie Ward has been appointed as chairman to drive the next phase of the company's growth as the importance of pharmacogenetics in drug development increases. He previously held senior positions at GSK R&D and various biotechnology companies in the US and UK.

In addition, Dominique Kleyn has been brought on as CEO and Dr Mark Caulfield has been appointed clinical director. Kleyn previously held leadership roles at Imperial College London and within the biotech sector; Caulfield is an expert in the genetics of cardiovascular disease, particularly hypertension. He is director of the William Harvey Research Institute at Bart's and the London School of Medicine and Dentistry at Queen Mary, University of London.

Commenting on his appointment, Dr Ward said: "I am delighted to have joined the strong team at London Genetics at a time when the importance of pharmacogenetics in drug development is becoming increasingly clear. This is a pivotal phase of the company's development as it works in partnership with biopharmaceutical companies to add value to drug development programmes."

Ms Kleyn added: "We have an exciting partnering programme lined up for the coming months and I look forward to working together with our founding institutions and the biopharmaceutical industry to build interactions that will help to make a difference to drug development."

London Genetics has broad therapeutic experience with a particular focus on cardiovascular drugs and cardiovascular safety.

22nd September 2009

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....
Top-10 Reasons Why You Should be Adding Asynchronous Virtual Touchpoints Between Your Real-time Meetings
...